IDEAYA Biosciences IDYA
NASDAQ IDYA
$37.56 -0.26 (-0.67%)
As of: Oct 2, 2026 · 11:49 AM EDT

IDEAYA Biosciences (IDYA) Net Equity Issued and Repurchased (2019 - 2026)

Updated

IDEAYA Biosciences' Net Equity Issued and Repurchased was $182.05 million in Q2 2026, compared with $410,000 a year earlier.

Analysis

IDEAYA Biosciences (IDYA) Net Equity Issued and Repurchased (2019 - 2026) Analysis & Trends

On a trailing twelve-month basis, IDEAYA Biosciences' Net Equity Issued and Repurchased was $185.12 million through Jun 30, 2026, down 31.0% year-over-year; for FY2025, it came in at $3.43 million, down 98.7% from FY2024.

  • Net Equity Issued and Repurchased shows a five-year compound annual growth rate of -49.1% (FY2020 to FY2025).
  • In earlier years, Net Equity Issued and Repurchased was $274.35 million in FY2024 (-2.4%), $281.17 million in FY2023 (+226.5%), $86.11 million in FY2022 (+0.1%) and $85.99 million in FY2021 (-14.6%).
  • The Q2 2026 figure marks the highest quarterly Net Equity Issued and Repurchased since Q4 2024.
  • Compared with a year earlier, Net Equity Issued and Repurchased was higher in two of the last six quarters, with an average decline of 38.5%.
  • The best year-over-year quarter for Net Equity Issued and Repurchased over five years was Q1 2022 (growth of 491.1%); the worst was Q4 2025 (a decline of 99.4%).
  • Per Business Quant data, IDYA's Net Equity Issued and Repurchased in the three quarters before Q2 2026 was $1.19 million (Q1 2026), $1.5 million (Q4 2025) and $384,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 43.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 6.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 9.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 47.70 Mn
10 IDEAYA Biosciences 3.70 Bn 776.31 Mn - 182.05 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 182.05 Mn
Mar 31, 2026 1.19 Mn
Dec 31, 2025 1.50 Mn
Sep 30, 2025 384,000.00
Jun 30, 2025 410,000.00
Mar 31, 2025 1.13 Mn
Dec 31, 2024 264.37 Mn
Sep 30, 2024 2.44 Mn
Jun 30, 2024 2.08 Mn
Mar 31, 2024 5.46 Mn
Dec 31, 2023 127.57 Mn
Sep 30, 2023 -249,000.00
Jun 30, 2023 151.28 Mn
Mar 31, 2023 2.56 Mn
Dec 31, 2022 -375,000.00
Sep 30, 2022 85.70 Mn
Jun 30, 2022 122,000.00
Mar 31, 2022 662,000.00
Sep 30, 2021 85.64 Mn
Jun 30, 2021 243,000.00
API Access

IDEAYA Biosciences Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=IDYA&period=max&api_key=YOUR_API_KEY